Evidence map›Paper›PMID 38535791›Full record

ArticleToxins2024

One-Step Affinity Purification of Leucine-Rich α

Ryoichi Shirai, Kana Shibata, Shinobu Fujii, Rikiro Fukunaga, Seiji Inoue

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Toxins, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Phospholipases ABiomolecules · 2025
    Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Ryoichi ShiraiDepartment of Biochemistry, Faculty of Pharmacy, Osaka Medical and Pharmaceutical University, Takatsuki 569-1094, Osaka, Japan.
Kana ShibataDepartment of Biochemistry, Faculty of Pharmacy, Osaka Medical and Pharmaceutical University, Takatsuki 569-1094, Osaka, Japan.
Shinobu FujiiDepartment of Biochemistry, Faculty of Pharmacy, Osaka Medical and Pharmaceutical University, Takatsuki 569-1094, Osaka, Japan.ORCID 0000-0003-0349-8919
Rikiro FukunagaDepartment of Biochemistry, Faculty of Pharmacy, Osaka Medical and Pharmaceutical University, Takatsuki 569-1094, Osaka, Japan.ORCID 0000-0001-8972-8863
Seiji InoueDepartment of Biochemistry, Faculty of Pharmacy, Osaka Medical and Pharmaceutical University, Takatsuki 569-1094, Osaka, Japan.
Osaka University of Pharmaceutical Sciences · JPMisasa Onsen Hospital · JP

Funding

Japan Society for the Promotion of Science JP12672137, JP10672074
6 · The paper itself

Abstract

Snakes contain three types of phospholipase A

Indexed as

ColubridaeGlycoproteinsAnimalsChromatography, AffinityCytochromes cHorsesLeucinePhospholipases A2Saccharomyces cerevisiaeCytochromes cGlycoproteinsLeucinePhospholipases A2Colubridaecytochrome cElapidaeleucine-rich α2-glycoproteinphospholipase A2phospholipase A2 inhibitorViperidae

Identifiers

PMID38535791
PMCPMC10975490
OpenAlexW4392355282

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.